Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Virtual Reality Versus Mental Practice On Balance And Gait In Patients With Multiple Sclerosis

30 oktober 2026 uppdaterad av: Ola Zaghloul Muhammad Ali Asal, Cairo University

This study is conducted to:

  • Investigate the effect of virtual reality based training on balance and risk of falling.
  • Investigate the effect of virtual reality based training on gait.
  • Investigate the effect of mental practice on balance and risk of falling.
  • Investigate the effect of mental practice on gait.
  • Compare between the effect of virtual reality based training and mental practice on balance and gait

Studieöversikt

Status

Rekrytering

Betingelser

Intervention / Behandling

Detaljerad beskrivning

Background: Multiple sclerosis affects the central integration of sensory afferents that causes disturbance of balance, postural control and gait. Exercise interventions performed through VR applications encourage participants to engage in challenging tasks that integrate motor and cognitive demands, enhance patients' sensory processing and integration systems and allows them to receive information feedback and improve the motivation of training. Mental Practice is a complex cognitive operation that is possible thanks to the use of sensory and perceptive processes that allow an individual to reactivate specific motor actions in the working memory.

Purpose: This study is conducted to Investigate the effect of virtual reality based training on balance and risk of falling, Investigate the effect of virtual reality based training on gait, Investigate the effect of mental practice on balance and risk of falling, Investigate the effect of mental practice on gait and to compare between the effect of virtual reality based training and mental practice on balance and gait.

Methods: Fifty four patients of both sexes with relapsing remitting MS (RRMS). The patients will be diagnosed as having RRMS based on careful clinical examination by neurologist and diagnosis will be confirmed by radiological investigations as magnetic resonance imaging (MRI). Patients will be recruited from the outpatient clinic of Faculty of Physical Therapy, Pharos University in Alexandria and private clinics. Patients in this study will be randomly divided into three groups.

  • Group (I) which will include 18 patients who will receive mental practice in addition to selected physical therapy .
  • Group (II) which will include 18 patients who will receive virtual reality based training in addition to selected physical therapy.
  • Group (III) which will include 18 patients who will receive selected physical therapy.

The treatment will be conducted 3 sessions per week for 6 weeks for 45 minutes.

Results: Data analysis with 2-way mixed Design MANOVA will be used to compare the groups for normally distributed data and Kruskal Wallis and Mann-Whitney tests will be used to compare the groups for non-parametric and not normally distributed data.

Studietyp

Interventionell

Inskrivning (Beräknad)

54

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studera Kontakt Backup

Studieorter

  • Egypten
    • Giza Governorate
      • Giza, Giza Governorate, Egypten
        • Rekrytering
        • Faculty of Physical Therapy, Cairo University

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

20 år till 35 år (Vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  1. Patients with RRMS.
  2. Patient's age will be range from 20 - 35 years..
  3. Patients are able to walk 10 meter with or without assistance.
  4. Patients with ≤ 6 according to an Expanded Disability Status Scale (EDSS).
  5. Patients are cognitively able to follow instructions.
  6. Patient's body mass index (BMI) will be ranged from 18.5 to 29.99 Kg/m2.

Exclusion Criteria:

  1. Patients with MS relapse in the last 30 days.
  2. Visual impairments interfering with VR.
  3. Severe spasticity or orthopaedic deformity.
  4. Recent musculoskeletal injury.
  5. History of epilepsy or motion sickness with VR.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Virtuell verklighet
Övrig: Virtual Reality

The virtual environment presented via Head Mounted Display (HMD) has three-dimensional presentation and the panoramic view that covers the users' field of view, it facilitates immersion in the virtual and distraction from the real world
Experimentell: Mental Practice
Övrig: Mental Practice

Mental Practice is among the recommended strategies to enhance performance. MP is a symbolic exercise, involving repeated mental imagery in the absence of any visible muscle contraction.
Experimentell: Selected Physical Therapy Program
Övrig: Selected Physical Therapy Program

Dual tasking and Task oriented training in static and dynamic forms

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Gait
Tidsram: 6 weeks

spatial, temporal and angular parameters as cadence, step length and range of motion of hip, knee and ankle will be measured using software analysis "Kinovea" Kinovea is a free, open-source 2D video analysis software. It does not generate a single composite "score". Instead, it measures quantitative biomechanical and kinematic metrics from recorded video.
6 weeks
Gait
Tidsram: 6 weeks

"10 minutes walk test" will be performed pre and post treatment by asking the patient to walk through a 12 meter walkway and calculate the time for 10 meters in tha walkway in two walking speeds( normal - fast) for 2 or 3 trials of each speed Speed > 1.2 m/s: Normal / Community AmbulatorAble to safely cross street intersections and navigate crowded environments.

0.8 - 1.2 m/s: Limited Community Ambulator/ Able to walk outdoors independently 0.4 - 0.8 m/s: Household Ambulator/ Mostly restricted to indoor walking; requires assistance or equipment outdoors.

< 0.4 m/s: Severe Functional Limitation
6 weeks
Balance
Tidsram: 6 weeks

static and dynamic balance will be assessed using "Berg Balance Scale" The Berg Balance Scale (BBS) is a 14-item clinical assessment scale designed to measure static balance and dynamic functional mobility, Point Scale: Each of the 14 tasks is rated on a 0 to 4 ordinal scale based on safety, independence, time held, or distance reached, Scores are summed across all items for a overall score ranging from 0 to 56 points (higher scores reflect better balance and mobility).
6 weeks
Balance
Tidsram: 6 weeks

"Timed Up and Go" test giving numerical data pre and post treatment about balance and risk of falling

Test is scored entirely by time (in seconds):

Time < 10 seconds: Normal / Completely IndependentFreely mobile; minimal to no fall risk 10 - 19 seconds: Mostly Independent, Reasonable balance and gait speed, generally low fall risk 20 - 29 seconds: Variable MobilityImpaired mobility, slower gait speed > 30 seconds: Severely Impaired, high fall risk
6 weeks

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

Cairo University

Utredare

  • Studierektor: Nagwa I Rehab, PhD, Cairo University
  • Studierektor: Rania M Tawfik, PhD, Cairo University
  • Studierektor: Ebtesam M Fahmy, PhD, Cairo University

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

1 mars 2026

Primärt slutförande (Beräknad)

15 mars 2027

Avslutad studie (Beräknad)

30 mars 2027

Studieregistreringsdatum

Först inskickad

17 mars 2026

Först inskickad som uppfyllde QC-kriterierna

30 oktober 2026

Första postat (Faktisk)

5 november 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

5 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

30 oktober 2026

Senast verifierad

1 mars 2026

Mer information

Termer relaterade till denna studie

Nyckelord

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • P.T.REC/012/006172

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera